US Stock MarketDetailed Quotes

KYMR Kymera Therapeutics

Watchlist
  • 47.780
  • +1.930+4.21%
Close Aug 23 16:00 ET
  • 47.780
  • 0.0000.00%
Post 19:18 ET
3.09BMarket Cap-19825P/E (TTM)

Kymera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
55.33%25.65M
8.67%10.29M
67.84%78.59M
196.70%47.89M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
-35.71%46.83M
5.66%16.14M
-53.03%9.55M
Operating revenue
55.33%25.65M
8.67%10.29M
67.84%78.59M
196.70%47.89M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
-35.71%46.83M
5.66%16.14M
-53.03%9.55M
Cost of revenue
Gross profit
Operating expense
27.85%76.58M
15.33%63.19M
17.32%244.12M
22.69%67.2M
14.34%62.24M
14.47%59.9M
17.69%54.79M
20.03%208.08M
11.16%54.77M
11.15%54.43M
Selling and administrative expenses
22.96%17.37M
14.40%14.37M
25.57%55.04M
22.27%14.23M
33.76%14.12M
28.08%14.13M
18.41%12.57M
20.61%43.83M
-0.89%11.64M
-1.04%10.56M
-General and administrative expense
22.96%17.37M
14.40%14.37M
25.57%55.04M
22.27%14.23M
33.76%14.12M
28.08%14.13M
18.41%12.57M
20.61%43.83M
-0.89%11.64M
-1.04%10.56M
Research and development costs
29.36%59.2M
15.61%48.82M
15.12%189.08M
22.81%52.97M
9.66%48.12M
10.83%45.77M
17.48%42.23M
19.87%164.25M
14.93%43.13M
14.54%43.88M
Operating profit
-17.38%-50.93M
-16.72%-52.91M
-2.65%-165.53M
50.01%-19.31M
-28.13%-57.51M
-6.30%-43.38M
-22.72%-45.33M
-60.41%-161.26M
-13.64%-38.63M
-56.73%-44.88M
Net non-operating interest income expense
93.35%8.86M
110.87%9.27M
187.97%18.57M
31.31%4.94M
146.91%4.64M
728.93%4.58M
1,666.27%4.4M
1,960.06%6.45M
3,905.32%3.77M
3,318.18%1.88M
Non-operating interest income
92.66%8.92M
109.81%9.34M
183.27%18.76M
30.65%5M
144.42%4.68M
679.80%4.63M
1,435.52%4.45M
1,257.38%6.62M
2,537.24%3.82M
1,432.80%1.92M
Non-operating interest expense
27.08%61K
25.45%69K
11.36%196K
-11.86%52K
13.89%41K
17.07%48K
34.15%55K
0.57%176K
15.69%59K
-48.57%36K
Other net income (expense)
-4.93M
Special income (charges)
--0
---4.93M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
--0
--4.93M
----
----
----
--0
--0
----
----
----
Income before tax
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
Income tax
Net income
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
Net income continuous Operations
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
Minority interest income
Net income attributable to the parent company
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
Basic earnings per share
13.43%-0.58
1.43%-0.69
12.20%-2.52
58.33%-0.25
-13.92%-0.9
14.10%-0.67
1.41%-0.7
-37.32%-2.87
9.09%-0.6
-41.07%-0.79
Diluted earnings per share
13.43%-0.58
1.43%-0.69
12.20%-2.52
58.33%-0.25
-13.92%-0.9
14.10%-0.67
1.41%-0.7
-37.32%-2.87
9.09%-0.6
-41.07%-0.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 55.33%25.65M8.67%10.29M67.84%78.59M196.70%47.89M-50.50%4.73M43.42%16.51M-1.62%9.47M-35.71%46.83M5.66%16.14M-53.03%9.55M
Operating revenue 55.33%25.65M8.67%10.29M67.84%78.59M196.70%47.89M-50.50%4.73M43.42%16.51M-1.62%9.47M-35.71%46.83M5.66%16.14M-53.03%9.55M
Cost of revenue
Gross profit
Operating expense 27.85%76.58M15.33%63.19M17.32%244.12M22.69%67.2M14.34%62.24M14.47%59.9M17.69%54.79M20.03%208.08M11.16%54.77M11.15%54.43M
Selling and administrative expenses 22.96%17.37M14.40%14.37M25.57%55.04M22.27%14.23M33.76%14.12M28.08%14.13M18.41%12.57M20.61%43.83M-0.89%11.64M-1.04%10.56M
-General and administrative expense 22.96%17.37M14.40%14.37M25.57%55.04M22.27%14.23M33.76%14.12M28.08%14.13M18.41%12.57M20.61%43.83M-0.89%11.64M-1.04%10.56M
Research and development costs 29.36%59.2M15.61%48.82M15.12%189.08M22.81%52.97M9.66%48.12M10.83%45.77M17.48%42.23M19.87%164.25M14.93%43.13M14.54%43.88M
Operating profit -17.38%-50.93M-16.72%-52.91M-2.65%-165.53M50.01%-19.31M-28.13%-57.51M-6.30%-43.38M-22.72%-45.33M-60.41%-161.26M-13.64%-38.63M-56.73%-44.88M
Net non-operating interest income expense 93.35%8.86M110.87%9.27M187.97%18.57M31.31%4.94M146.91%4.64M728.93%4.58M1,666.27%4.4M1,960.06%6.45M3,905.32%3.77M3,318.18%1.88M
Non-operating interest income 92.66%8.92M109.81%9.34M183.27%18.76M30.65%5M144.42%4.68M679.80%4.63M1,435.52%4.45M1,257.38%6.62M2,537.24%3.82M1,432.80%1.92M
Non-operating interest expense 27.08%61K25.45%69K11.36%196K-11.86%52K13.89%41K17.07%48K34.15%55K0.57%176K15.69%59K-48.57%36K
Other net income (expense) -4.93M
Special income (charges) --0---4.93M--------------0--0------------
-Less:Impairment of capital assets --0--4.93M--------------0--0------------
Income before tax -8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M
Income tax
Net income -8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M
Net income continuous Operations -8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M
Minority interest income
Net income attributable to the parent company -8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M
Basic earnings per share 13.43%-0.581.43%-0.6912.20%-2.5258.33%-0.25-13.92%-0.914.10%-0.671.41%-0.7-37.32%-2.879.09%-0.6-41.07%-0.79
Diluted earnings per share 13.43%-0.581.43%-0.6912.20%-2.5258.33%-0.25-13.92%-0.914.10%-0.671.41%-0.7-37.32%-2.879.09%-0.6-41.07%-0.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg